08.01.24 -- Outsourcing At Cerus: Blood, Sweat … And FTEs?

Not really into choosing extended time away and exhibit halls over the simple pleasures of summertime? No reason to put your CDMO search on hold – Outsourced Pharma Capacity Update’s PARTNER WEEK is now available on-demand. Take the travel and headache out of your plans and tune in right from your computer. Assess potential fit for your next drug development project in convenient 20-minute segments – all grouped by molecule type. Detailed presentations include current available capacity across featured capabilities. View each session on-demand here.

You might not need to outfit your whole facility to take advantage of single-use technology. Assemblies offer a straightforward path to standardizing equipment.

The heterogeneity of a biologic has implications for a therapy's safety and efficacy. Explore challenges associated with charged variants, including mAbs and fusion proteins.

Discover how building a product development program with a long-term vision and adopting a holistic PPQ and CPV strategy from the outset are now crucial.

Explore five areas that can form part of a quality risk management strategy to ensure the compliant manufacturing of sterile drug products.

Improving your ADC’s chance of clinical success requires an understanding of what potential obstacles lie ahead and what capabilities and expertise are necessary to overcome them.

In the biopharmaceutical development world, Quality by Design cuts risk, streamlines processes, and speeds up regulatory approval.

What sustainable manufacturing processes best address Oligonucleotide environmental impact while maintaining scalability?

By prioritizing quality, biotech companies can ensure a smoother development process, safeguard patient well-being, and bring life-saving treatments to market faster.

Review how following regulatory guidelines and partnering with a reliable contract manufacturer ensures the highest standards are met in pharmaceutical research and quality control.

What's your development and manufacturing outsourcing strategy based on? Do you have the right contracts and external relationships in place to successfully implement that strategy? Are there new models for sponsor-CDMO partnerships? Join Outsourced Pharma Live on August 13th as our panel of professionals will provide personal analysis and ideas for determining how you might best conduct your development and manufacturing activities, outsourcing business models, and external relationships.

Learn more about the capacity of our new facility and how our highly automated cGMP capabilities can help produce your innovative therapeutic and reach patients in need.

Streamline your journey to market by using the same proven CHO cell line and vectors from discovery through to commercial production.

With our top-tier services, reliable expertise, and global network of laboratories, we provide unparalleled support to improve countless lives.

A molecule with great therapeutic potential is only as good as its formulation. For patients, a successful formulation closes the gap between theory and therapy.